Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquinol-cytochrome c reductase complex assembly factor 2 (UQCC2) is a mitochondrial protein encoded by the UQCC2 gene on chromosome 6. UQCC2 is essential for the proper assembly of complex III (cytochrome b-c1 complex) in the mitochondrial electron transport chain. It functions as an assembly factor that facilitates the expression and stability of the mtDNA-encoded cytochrome b protein, working in concert with UQCC1. UQCC2 localizes to the mitochondrial nucleoid and inner membrane and is critical for cytochrome b biogenesis, affecting mitochondrial ATP production, cellular oxygen consumption, insulin secretion by pancreatic beta-cells, and muscle differentiation. Mutations in UQCC2 lead to complex III deficiency manifesting as neonatal lactic acidosis, intrauterine growth retardation, and renal dysfunction. Currently, UQCC2 is not considered a therapeutic target since no drugs directly interact with it, but it is a key player in mitochondrial biology and monogenic mitochondrial disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquinol-cytochrome c reductase complex assembly factor 2 (UQCC2).